Lucid Scientific

Lucid Scientific has developed Resipher, a novel instrumentation platform that transforms a standard 96-well plate into a real-time oxygen consumption reader for long-term cell culture experiments. This addresses a key bottleneck in metabolic research by enabling continuous, non-invasive monitoring of cellular respiration from inside an incubator over days to months. The company serves the life science research tools market, offering a versatile system compatible with 2D monolayers, 3D organoids, tissue slices, and other complex models. As a private company, it appears to be in an early revenue stage, commercializing its hardware and consumables directly to academic and industrial research labs.

Resipher: A handheld, incubator-compatible reader that uses optical sensors to enable real-time, non-invasive monitoring of oxygen consumption (OCR) in standard 96-well plates over extended durations (days to months). Compatible with 2D, 3D, and complex cell models.

The primary competitor is Agilent Technologies, the dominant player with its Seahorse XF Analyzers. Other competitors include Oroboros Instruments (high-resolution respirometry) and various fluorescence/luminescence plate readers adapted for endpoint metabolic assays. Lucid's key differentiators are real-time monitoring from inside the incubator and compatibility with very long-term cultures.